𝔖 Bobbio Scriptorium
✦   LIBER   ✦

117 Oxaliplatin plus capecitabine in advanced neuroendocrine tumours (NETs): Is the new WHO classification applicable to daily practice?

✍ Scribed by L. Catena; E. Bajetta; G. Procopio; L. Ferrari; S. Della Torre; E. Verzoni; E. Bichisao; R. Buzzoni; S. Iacobelli; A. Falcone


Book ID
118620292
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
168 KB
Volume
1
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.